1. Home
  2. LUNG vs FRGE Comparison

LUNG vs FRGE Comparison

Compare LUNG & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • FRGE
  • Stock Information
  • Founded
  • LUNG 1995
  • FRGE 2014
  • Country
  • LUNG United States
  • FRGE United States
  • Employees
  • LUNG N/A
  • FRGE N/A
  • Industry
  • LUNG Industrial Specialties
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • LUNG Health Care
  • FRGE Technology
  • Exchange
  • LUNG Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • LUNG 251.5M
  • FRGE 196.1M
  • IPO Year
  • LUNG 2020
  • FRGE N/A
  • Fundamental
  • Price
  • LUNG $6.23
  • FRGE $0.94
  • Analyst Decision
  • LUNG Buy
  • FRGE Strong Buy
  • Analyst Count
  • LUNG 6
  • FRGE 3
  • Target Price
  • LUNG $11.92
  • FRGE $4.50
  • AVG Volume (30 Days)
  • LUNG 242.6K
  • FRGE 675.4K
  • Earning Date
  • LUNG 02-19-2025
  • FRGE 11-06-2024
  • Dividend Yield
  • LUNG N/A
  • FRGE N/A
  • EPS Growth
  • LUNG N/A
  • FRGE N/A
  • EPS
  • LUNG N/A
  • FRGE N/A
  • Revenue
  • LUNG $79,302,000.00
  • FRGE $79,799,000.00
  • Revenue This Year
  • LUNG $22.26
  • FRGE $19.18
  • Revenue Next Year
  • LUNG $18.72
  • FRGE $34.32
  • P/E Ratio
  • LUNG N/A
  • FRGE N/A
  • Revenue Growth
  • LUNG 22.34
  • FRGE 18.08
  • 52 Week Low
  • LUNG $5.46
  • FRGE $0.80
  • 52 Week High
  • LUNG $14.84
  • FRGE $4.02
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.37
  • FRGE 39.86
  • Support Level
  • LUNG $5.72
  • FRGE $0.90
  • Resistance Level
  • LUNG $6.28
  • FRGE $1.25
  • Average True Range (ATR)
  • LUNG 0.40
  • FRGE 0.09
  • MACD
  • LUNG -0.03
  • FRGE -0.01
  • Stochastic Oscillator
  • LUNG 19.85
  • FRGE 2.14

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: